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Role of inflammation in right ventricular damage and repair
following experimental pulmonary embolism in rats
John Albert Watts, Michael Aaron Gellar, Maria Obraztsova, Jeffrey Allen Kline and John Zagorski
Emergency Medicine Research, Carolinas Medical Center, Charlotte, NC, USA
Pulmonary embolism (PE) is a major cardiopulmonary
disease with an incidence of 1 per 1000 individuals in a
year, hospitalizing approximately 150,000 Americans per
year (Stein et al. 2003), and having a mortality rate that
exceeds 15% in the first 3 months after diagnosis (Goldhaber
& Elliott 2003a,b; White 2003). The incidence of mortality
increases dramatically with the presence of right ventricular
(RV) dysfunction based on echocardiographic indexes
(Kasper et al. 1997; Ribeiro et al. 1997; Ribeiro et al. 1999;
Kreit 2004; Schoepf et al. 2004) or liberation of cardiac
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Summary
Right ventricular (RV) dysfunction is associated with poor clinical outcome follow-
ing pulmonary embolism (PE). Previous studies in our laboratory show that influx of
neutrophils contributes to acute RV damage seen in an 18 h rat model of PE. The
present study describes the further progression of inflammation over 6 weeks and
compares the neutrophil and monocyte responses. The RV outflow tract became
white in colour by day 1 with influx of neutrophils (tissue myeloperoxidase activity
increased 17-fold) and mononuclear cells with characteristics of M1 phenotype
(high in Ccl20, Cxcl10, CcR2, MHCII, DNA microarray analysis). Matrix metallo-
proteinase activities were increased and tissue was thinned to produce a translucent
appearance in weeks 1 through 6 in 40% of hearts. RV contractile function was sig-
nificantly reduced at 6 weeks of PE. In this later phase, there was accumulation of
myofibroblasts, the presence of mononuclear cells with M2 characteristics (high in
scavenger mannose receptors, macrophage galactose lectin 1, PDGFR1, PDGFRb),
enrichment of the subendocardial region of the RV outflow tract with neovesels (a-
smooth muscle immunohistochemistry) and deposition of collagen fibres (picrosirius
red staining) beginning scar formation. Thus, while neutrophil response is associated
with the early, acute inflammatory events, macrophage cells continue to be present
during the proliferative phase and initial deposition of collagen in this model,
changing from the M1 to the M2 phenotype. This suggests that the macrophage cell
response is biphasic.
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biomarkers such as troponin proteins into the blood (Gian-
nitsis et al. 2000; Meyer et al. 2000; Kline et al. 2006; Lippi
& Favaloro 2008). Even among survivors of submassive PE
without evidence of shock, 40% of survivors have persistent
RV dysfunction (Kline et al. 2006; Stevinson et al. 2007).
These data underscore the importance of understanding the
mechanisms of RV damage resulting from PE.
Current literature provides only minimal insight into the
mechanism of persistent RV dysfunction after PE. The
abrupt rise in pulmonary vascular resistance following PE
increases RV peak systolic pressure and enlarges the RV
(Ribeiro et al. 1997; Ribeiro et al. 1999). This increases RV
wall tension causing myocyte stretch, increased work and
compression of coronary vessels, resulting in functional RV
ischaemia. This interpretation was made as early as 1949
(Dack et al. 1949) and has continued to be the predominant
explanation for RV dysfunction (Vlahakes et al. 1981; Gold
& Bache 1982; Wood 2002; Kreit 2004). The importance of
RV inflammation to the development and extension of RV
injury has only recently been examined in PE.
Our previous studies indicate a central role of neutrophils
in the pathogenesis of acute RV damage after experimental
PE in rats (Watts et al. 2006; Zagorski et al. 2007). RV
tissue obtained at autopsy from humans with PE also shows
the presence of neutrophils and monocytes (Iwadate et al.
2001, 2003). This study examines the 6-week time course of
neutrophil and monocyte ⁄macrophage cell infiltration and
the role of these cells in the proliferative and resolution
phases of myocardial healing in the rat model of PE.
Materials and methods
Animals
Experiments were performed using male Sprague–Dawley
rats weighing between 300 and 375 g at the start of the
experimental period. All experiments were conducted with
the approval of the Institutional Animal Care and Use Com-
mittee of the Carolinas Medical Center in accordance with
the Guide for the Care and Use of Laboratory Animals.
Pulmonary embolism model
Pulmonary embolism was induced in anaesthetized animals
(xylazine 3 mg ⁄kg and ketamine 70 mg ⁄kg, IP) by injecting
polystyrene microspheres (2.0 million ⁄100 g body wt,
24 ± 1 lm, 7525A; Duke Scientific, Palo Alto, CA, USA)
into the right jugular vein as previously described (Zagorski
et al. 2003; Watts et al. 2006; Zagorski et al. 2007, 2008).
Vehicle-treated animals received vehicle (0.01% Tween 20
at 0.16 ml ⁄100 g body wt), but not microspheres. Surgical
incisions were sealed with staples and animals recovered for
the period indicated in each experimental group.
In vivo measurements
Animals were anaesthetized with xylazine (3 mg ⁄kg) and ke-
tamine (70 mg ⁄kg) and placed on a warming pad at the
indicated time point (day 1, day 4, 1, 2, 3, 4 or 6 weeks).
Breathing rate was manually counted. A 2-French microma-
nometer (Millar Instruments, Houston, TX, USA) was
placed in the left carotid artery to measure systemic pres-
sures and heart rate. A 2-French bent Millar micromano-
meter was inserted into the jugular vein and placed into the
RV intermittently to assess RV pressures. Acknowledge
software (Biopac Systems, Inc., Santa Barbara, CA, USA)
was used to acquire the pressure data. PE-50 tubing was
used to aspirate arterial blood (0.4 ml) for blood chemistry
(StatProfile Ultra analyzer; Nova Biomedical, Waltham, MA,
USA). An additional blood sample (5 ml) was removed and
plasma was aliquoted and stored ()70 C) for subsequent
analysis of cardiac troponin I content (ELISA #2010-2-HSP;
Life Diagnostics, Inc., West Chester, PA, USA).
In vitro RV outflow contractile force measurements
Hearts were isolated in anaesthetized rats via midline thora-
cotomy and placed in ice-cold saline. The aorta was per-
fused for 3–5 min at 60 mmHg in a non-recirculating,
temperature-controlled (37 C) system, using Krebs–Hense-
leit bicarbonate buffer as previously described (Watts et al.
2006; Zagorski et al. 2007). RV-free walls were isolated and
a strip of muscle (approximately 1 mm2 diameter) was cut
longitudinally from the midline of the outflow tract. Muscle
strips were placed into a tissue bath, containing Krebs–
Henseleit bicarbonate buffer (37 C, gassed with 95%
O2 ⁄5% CO2) and were tied to the fixed point and the iso-
metric tension transducer with digital micrometer in the
Refined Myograph System (Kent Scientific, Torrington, CT,
USA). Strips were paced at 10 ms duration, 80 V and
0.2 Hz using platinum plate electrodes, which were placed
on each side of the muscle tissue. Data were recorded using
Acknowledge software (Biopac Systems, Inc., Goletta, CA,
USA). Length–tension curves were constructed using
0.25 mm increments in length to determine contractile force
at the optimum length resulting in maximum active force
(mN ⁄mm2) cross-sectional area. The components were cal-
culated as follows: mNewton = gm tension · 9.807; mm2
cross-section area = wet wt ⁄optimum length, assuming
specific gravity = 1.0.
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Biochemical measurements
Hearts were perfused as described above. RV-free walls were
isolated, weighed and then frozen using liquid nitrogen-
cooled Wallenberger tongs. Frozen RV tissues were pulver-
ized using a liquid nitrogen-cooled, stainless steel custom
mortar and pestle. Frozen powders were stored at )70 C
until analysis.
Myeloperoxidase activity was determined in heart extracts
and normalized for total protein as previously described
(Zagorski et al. 2003; Watts et al. 2006; Zagorski et al.
2007). Protein concentrations were determined from the BCA
assay (Pierce, Inc., Rockford, IL, USA). Gelatin zymography
was performed as follows. Protein extracts were prepared by
homogenizing frozen RV powder (approximately 25 mg)
from individual hearts in phosphate-buffered saline. Extracts
were centrifuged (9,500 · g, 5 min, 23 C) and protein con-
centration was determined in supernatants. The protein
extracts of 8–10 hearts were pooled in equal concentration
for all groups of hearts. Aliquots of these extracts containing
20 lg of total RV protein in PBS were combined with 1· lith-
ium dodecyl sulfate (LDS) sample buffer minus reducing
agent and were loaded in gels without heating. Zymogram
gels were pre-poured using Novex NuPage 10% minigels
with gelatin substrate (Invitrogen, Carlsbad, CA, USA). Gels
were electrophoresed, renatured in situ and allowed to digest
gel substrate overnight. Gels were then stained with Amido
Black as recommended by the vendor (Invitrogen).
Histology
Hearts were isolated from anaesthetized rats and perfused
briefly as described above to remove blood from the coro-
nary vessels. The RV tissue was then dissected and the basal
outflow tract was isolated, fixed in 10% neutral buffered
formalin, embedded in paraffin, sectioned, de-parafinized, re-
hydrated and stained. Monocyte ⁄macrophages were stained
by immunohistochemistry using mouse antirat CD68, clone
number ED1 (MCA341R; Serotec, Inc., Raleigh, NC, USA)
primary antibody, the Animal Research Kit (ARK; Dakocy-
tomation, Carpenteria, CA, USA) kit and biotinylated mouse
secondary antibody with mouse Blocking Reagent. Sections
were treated with proteinase K (20 lg ⁄ml in PBS) and the
primary antibody was added for 60 min. Slides were incu-
bated for 15 min in peroxidase-conjugated streptavidin and
5 min in diaminobenzidine ⁄hydrogen peroxidase and were
then counter stained with 0.03% aqueous light green stain
(Polysciences, Warrington, PA, USA). Negative controls were
prepared for each heart sectioned by eliminating the primary
antibody. Smooth muscle actin (a-SMA) was labelled with
mouse monoclonal anti-actin, Clone 1A4 (A 5228; Sigma-
Aldrich, St. Louis, MO, USA), including negative controls.
Collagen was identified using the sequence of Weigert’s hae-
matoxylin (#s216BA and s216BB; Polysciences), alcian blue
solution (#A35-500; Sigma-Aldrich), and then picrosirius red
solution (0.1% Sirius Red F3B Aldrich #36,554-8; Sigma-
Aldrich) in saturated aqueous picric acid (#925-40; Sigma-
Aldrich). Sections were then rinsed in 0.01 N HCl for
2 min, dehydrated, cleared and mounted with cover slips.
Microarray analysis
Hearts were isolated and perfused to remove coronary vascu-
lar blood. RV tissue was collected from five animals in each
of four groups: day 1 PE, day 1 vehicle; week 6 PE, week 6
vehicle. RV tissues were quick-frozen in liquid nitrogen and
stored at )70 C. Frozen RV tissue was crushed using a
custom-built, stainless steel, mortar and pestle chilled with
liquid nitrogen. Approximately 100 mg of tissue powder from
each heart was then processed for RNA by the Trizol method
(Invitrogen). The extracted RNAs were purified on Qiagen
RNeasy columns and 5 lg total RNA was converted to
double-stranded cDNA with a Superscript double stranded
cDNA synthesis kit (Invitrogen). The cDNA was then tran-
scribed into biotin-labelled cRNA by in vitro transcription
(IVT) with the Affymetrix IVT Labeling Kit. The biotin-
labelled cRNAs were fragmented non-enzymatically accord-
ing to Affymetrix procedures. Each fragmented sample was
spiked with bioB, bioC, bioD and cre which served as hybrid-
ization controls. The fragmented cRNAs were then hybridized
to Affymetrix Rat Genome 230 v2.0 microarrays in Affyme-
trix hybridization buffer for 16 h at 45 C. The hybridized
arrays were washed and fluorescently stained in the Affyme-
trix Fluidics Station 400 following Affymetrix procedures.
Each array was scanned twice by the Agilent Gene Array
Scanner G2500A (Agilent Technologies, Palo Alto, CA, USA).
Statistical analysis
Values are presented as mean ± SE. Time course data were
collected for individual animals in each time point, and thus
represent independent groups for statistical analysis. Multi-
ple independent groups were compared using anova with
Tukey’s post hoc testing. Significance was determined as
P < 0.05 using two-tailed testing. Microarray data were
analysed with Genesifter web-based software (VizX Labs,
Seattle, WA, USA). Affymetrix ‘.cel’ files were uploaded to
the Genesifter web site using GC-RMA normalization.
Five independent arrays were analysed for each group.
Statistical analyses compared PE and vehicle at day 1 and
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PE and vehicle at week 6 using t-tests (P < 0.05) and Benja-
mini and Hochberg adjustment for false discovery rates. All
microarray data have been deposited in the NIH ⁄NCBI
GEO database (http://www.ncbi.nlm.nih.gov/projects/geo)
GEO accession no. GSE6104 (day 1), GSE11851 (week 6).
Results
In vivo responses to PE
Pulmonary embolism caused a significant increase in breath-
ing rate (141 ± 9 breaths per min in PE vs. 90 ± 3 vehicle)
and pleural effusion (8.3 ± 1.5 ml) on day 1 (Table 1). The
PE also produced mild hypotension (93 ± 14 peak systolic
arterial pressure in PE vs. 128 ± 4 mmHg in vehicle) and
elevated RV peak systolic pressure (36 ± 3 in PE vs.
30 ± 1 mmHg in vehicle) on day 1 together with hyper-
lactacidemia and hypoxemia. These abnormalities tended to
normalize on day 4 and week 1 (Table 1) and were not
different by 6 weeks.
Cardiac changes
Over the 6-week course studied, PE produced gross evidence
of RV damage. In contrast to healthy hearts (Figure 1a),
PE-stressed hearts show a focal, white plaque on day 1
(Figure 1b, arrow). Three weeks later, this white plaque
transformed to a sharply demarcated, transparent area in
the RV base (Figure 1c, arrow), which persisted through
week 6 (Figure 1d, arrow). No changes were observed in the
apical portion of the RV or in the LV during any period of
the experiment. This pattern of macroscopic injury was
observed in approximately 40% of animals (11 of 29) by
week 6 after PE. The RV outflow tract muscle contractile
force was significantly reduced 6 weeks after PE, compared
with contractile force in vehicle-treated animals (4.6 ± 0.5
PE vs. 7.2 ± 0.6 mN ⁄mm2 vehicle, mean ± SE, n = 22 PE,
n = 11 vehicle, P < 0.003, t-test). Coincident with the devel-
opment of the white plaque in the RV base, circulating con-
centrations of cardiac troponin I increased from
undetectable (<0.05 ng ⁄ml) to 3.00 ± 0.76 ng ⁄ml plasma.
This confirms the presence of cardiomyocyte necrosis during
the first 24 h of the PE. Troponin release resolved to base-
line levels by day 4 after PE.
Coincident with the development of the white plaque in
the RV base and cardiac troponin leak, the RV content of
myeloperoxidase activity, a marker of neutrophil cell con-
tent, increased 17-fold on day 1 (Figure 2). This high MPO
activity declined on day 4 after PE and returned to normal
Table 1 In vivo physiological
parameters
Group Breaths ⁄min
Pleural
effusion Lactate PO2 PSAP RVPSP
Veh D1 90 ± 3 ND 1 ± 0.1 83 ± 6 128 ± 4 30 ± 1
PE D1 141 ± 9* 8.3 ± 1.5* 2.8 ± 0.4* 62 ± 5* 93 ± 14* 36 ± 3*
PE D4 105 ± 2* ND 1.7 ± 0.4 61 ± 6* 119 ± 5 38 ± 2*
PE W1 101 ± 4 ND 0.9 ± 0.2 69 ± 2 131 ± 5 34 ± 3
PE W2 95 ± 5 ND 0.4 ± 0.1 76 ± 3 140 ± 6 31 ± 2
PE W4 90 ± 3 ND 0.9 ± 0.1 67 ± 2 145 ± 7 32 ± 2
PE W6 95 ± 5 ND 0.8 ± 0.1 70 ± 3 146 ± 5 32 ± 2
Veh W6 94 ± 4 ND 0.1 ± 0.1 86 ± 4 135 ± 6 28 ± 2
ND, none detected; PSAP, peak systolic arterial pressure (mmHg); RVPSP, right ventricular
peak systolic pressure (mmHg).
*Significant difference from vehicle day 1. n = 8–10 ⁄ group.
(a) (b)
(d)(c)
Figure 1 Pictures of hearts taken 6 weeks after vehicle treat-
ment (a), on day 1 (b), week 3 (c) or week 6 (d) after PE.
Arrows point to the right ventricular outflow tract in each
panel. Bar = 3 mm.
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by week 1 after PE. Gelatin zymography (Figure 3) revealed
a peak activity at 90 kDa, suggesting the presence of ele-
vated MMP-9 (Van den Steen et al. 2002), and a 200 kDa
activity, identified as the homodimer form of MMP-9 (Van
den Steen et al. 2002) on day 1 after PE. Three other
unidentified gelatinase activity bands, observed in the
57 kDa range appear to have activity peaking on day 4 and
persisting at elevated levels throughout the 6-week period.
Taken together, the elevated MPO and MMP-9 activity sug-
gest the presence of neutrophilic infiltration in the RV after
PE. We further tested the hypothesis that neutrophils con-
tributed to RV damage by treating rats with intravenous
anti-PMN antibody (0.2 ml containing 1 mg ⁄ rat, product
#AIA51140; Accurate Chemical and Scientific Corp., West-
bury, NY, USA) 15 min before inducing PE. As previously
described, anti-PMN treatment reduces the accumulation of
MPO activity and prevented RV dysfunction day 1 after PE
(Watts et al. 2006). The present data (Figure 3) show that
this treatment also abolished the 200 and 90 kDa MMP9
bands, but not the 57 kDa band.
Histology
Histological analyses focused on detection of mono-
cyte ⁄macrophages, collagen and a-SMA. The outflow tract
of the RV of hearts 6 weeks after vehicle treatment (no PE)
showed few CD68+ cells (Figure 4a), collagen staining was
identified around blood vessels and in spaces between car-
diomyocytes (Figure 4b), and a-SMA staining was confined
to the walls of blood vessels (Figure 4c).
Hearts stained 1 day after PE show clusters of CD68+
cells within the RV outflow tract (Figure 5a). On day 4,
the CD68+ cells are more numerous and appear to be
clustered in areas where muscle damage is evident
(Figure 5b). Examination of hearts 1 week after PE shows
that CD68+ cells are prevalent throughout the region of
the RV outflow tract that is thinned (Figure 5c). The
CD68+ cells are found throughout the loose connective tis-
sue region of the outflow tract by week 3 after PE (data
not shown) and by week 6 after PE (Figure 5d). The
CD68+ cells appear to be excluded from the endocardial
side of this region, where fibrous material is observed at
6 weeks after PE (Figure 5d). Stain was not evident in cor-
responding sections when the procedure was performed
with the omission of the primary antibody from the stain
procedure (data not shown).
Collagen distribution was observed in the serial sections
of those hearts examined for CD68 staining. The stain pat-
tern revealed by picrosirius red indicated that collagen was
disbursed between cardiomyocytes, along the epicardial layer
and around blood vessels 1 day after PE (Figure 6a, arrows).
A similar stain pattern was observed in hearts from vehicle-
treated animals (Figure 4b). At day 4 after PE, there was a
large accumulation of collagen in the endocardial part of
the outflow tract in the space devoid of cardiomyocytes
(Figure 6b, arrows). Collagen content also appeared to
increase between myocytes in some parts of the tissue. At
week 1 after PE, collagen staining was predominantly found
in the endocardial region of the thinned RV outflow tract
(Figure 6c), a pattern that persisted into week 6 (Figure 6d).
The region containing the increased collagen deposition in
Figure 6d is the region where CD68+ cells appeared to be
excluded in Figure 5d.
Smooth muscle actin immunohistochemistry showed
regions of positive staining associated with blood vessels 1
and 4 days (Figure 7a,b) after PE. A similar pattern of stain
was observed in hearts of vehicle-treated animals (Figure 4c).
By week 1 after PE, diffuse a-SMA staining was also
observed in the subendocardial region (Figure 7c) where the
collagen deposition was observed with picrosirius red stain-
ing (Figure 6c). The a-SMA stain was found in discrete
regions of the subendocardial muscle layer at 6 weeks after
PE (Figure 7d). Higher magnification of the outflow tract at
1 and 6 weeks after PE, taken from the points indicated by
the white arrows, are shown in Figure 7c,d inserts. These
views revealed that the a-SMA stain occurred in small blood
vessels that formed in subendocardial layer. When the pri-
mary antibody for a-SMA was omitted from the stain proce-
dure, there were no positive cells observed on any slide
(data not shown). Microarray data also show increased
Figure 2 Myeloperoxidase activity measured in right ventricular
tissue vehicle treatment (day 1 or week 6) or after PE (day 1, day
4 and weeks 1, 2, 4 and 6). Values are mean ± SE, n = 8–10
hearts per group. Asterisks indicate a significant difference from
other groups (*) or a significant difference from vehicle (**).
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Figure 3 Gelatinase zymogram from
right ventricular tissue isolated from
animals on day 1 and week 6 after
vehicle treatment or at the indicated
times after PE. The right panel shows a
separate experiment determining
gelatinase activity on day 1 after PE
and day 1 after PE in animals treated
with anti-PMN antibody to reduce
neutrophil influx into RV tissue.
Extracts from 8 to 10 hearts were
pooled for each group. Density
absorbance values are graphed for each
of the major bands of activity.
(a) (c)(b)
Figure 4 Representative sections taken from a 6-week vehicle heart and stained with CD68 immunohistochemistry for (a) monocytes,
(b) picrosirius red for collagen or (c) a-SMA for smooth muscle or myofibroblasts. Arrows indicate the structures staining positive in
each panel.
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a-SMA content in the hearts 6 weeks after PE (7.7-fold
elevated compared with 6 week vehicle, P = 0.0001), while
there was very little increase during the acute inflammatory
phase on day 1 (1.7-fold elevated compared with day 1
vehicle, P = 0.0034).
Microarray
A comprehensive evaluation of hierarchical clustering, Kyoto
Encyclopedia of Genes and Genomics (KEGG) and Gene
Ontology (GO) reports for gene changes on day 1 has recently
been published (Zagorski et al. 2008). A broad transcriptional
evaluation of the changes observed at 6 weeks is being pre-
pared; however, a focused evaluation of these data was made
to begin to assess markers identified in the literature to be
characteristic of M1 or M2 subtypes of mononuclear cells
(Figure 8) (Mantovani et al. 2005; Yrlid et al. 2006; Zymek
et al. 2006; Martinez et al. 2006, 2008). The emerging pattern
was that markers identifying characteristics of M1 cells
(Ccl20, Cxcl10, Ccr2, MHCII) were significantly elevated at
(a) (b)
(d)(c)
Figure 5 Histology of the right ventric-
ular outflow tract seen with CD68
immunohistochemistry identifying
monocyte ⁄macrophage cells. (a, arrows)
CD68+ cells are in clusters in the right
ventricular outflow tract at day 1 after
PE, (b, arrows) aggregated in regions of
damage at day 4 after PE, (c, arrow) in
the debrided, thinned outflow tract
week 1 after PE and (d) in the loose
connective tissue above the developing
fibres seen on the endocardial side
6 weeks after PE. Sections are serial to
those in Figures 6 and 7. Endocardial
side is downward.
(a)
(c) (d)
(b)
Figure 6 Histology of the right
ventricular outflow tract seen with
picrosirius red collagen stain. (a,
arrows) Collagen fibres are seen
between myocytes and at the epicardial
area on day 1 after PE, (b, arrow) in
the damaged region at day 4 after PE,
(c, arrow) in the endocardial side of the
debrided, thinned outflow tract week 1
after PE and (d) in the endocardial side
6 weeks after PE. Sections are serial to
those in Figures 5 and 7. Endocardial
side is downward.
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day 1 (Figure 8a) compared with vehicle, while markers char-
acteristic of M2 cells (scavenger mannose receptors, macro-
phage galactose N-acetyl-galactosamine specific lectin 1,
PDGF receptor1 and PDGF-receptor b) were significantly ele-
vated at week 6 (Figure 8b) compared with vehicle.
Discussion
This study shows the central role of neutrophils and macro-
phages in producing RV damage and remodelling after PE in
the rat heart. The evidence includes gross pathology,
(c) (d)
(b)(a)
Figure 7 Histology of the right
ventricular outflow tract seen with a-
SMA stain. (a, arrows) Stain is localized
to blood vessels on day 1 after PE (b)
and day 4 after PE. (c, black arrow)
Stain is in blood vessels 1 week after PE
and also in a diffuse stain pattern
within the endocardial side. The insert
comes from the area indicated by the
white arrow, showing neovessels. (d,
black arrow) Stain is observed in blood
vessels at 6 weeks. The white arrow (d)
indicates the region where the insert
was taken to show neovessel formation.
Sections are serial to those in Figures 5
and 6. Endocardial side is downward.
(a) (b)
Figure 8 Differential expression of genes describing mononuclear cell M1 and M2 subtypes in right ventricles at (a) day 1 (b) and
week 6 after PE in comparison with time-matched vehicle-treated tissue. Fold changes are statistically significant using t-test with
Benjamini and Hochberg adjustment for false discovery rates (n = 5 arrays ⁄ group). Gene symbols are CC chemokine ligand 20 also
known as MIP-3a (Ccl20), CXC chemokine ligand 10 also known as IP-10 (Cxcl10), CC chemokine receptor 2 (Ccr2), major histo-
compatibility complex II (Fcgr2b), scavenger mannose receptors (Mrc1), macrophage galactose specific lectin 1 (CD301, Mgl1), plate-
let-derived growth factor receptor 1 (PDGFR1) and platelet-derived growth factor receptor beta polypeptide (PDGFRb).
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contractile dysfunction, biochemical measurements and his-
tological observations. Early in the course, the RV became
white in colour, had elevated MPO and MMP-9 activity
(indicating the presence of neutrophils), troponin was
released (indicating necrosis) and histology showed the pres-
ence of macrophage cells. Over the subsequent weeks, the
RV outflow tract had decreased contractile function, and
became transparent with the death of muscle cells, collagen
deposition and the appearance of neovessels. Monocyte sub-
types paralleled the morphology with M1 characteristics at
the early stage and M2 phenotype in the healing stage.
These events approximate those observed in the left ventricle
in response to myocardial infarction, which have been
divided into three general phases, the inflammatory phase,
the proliferative phase and resolution of inflammation and
scar formation (Frangogiannis 2006; Zymek et al. 2006).
Our previous studies show that the influx of neutrophils
in the inflammatory phase occurs between 6 and 18 h after
PE and that CINC-1 is a primary chemokine involved in
recruiting neutrophils (Watts et al. 2006; Zagorski et al.
2007). This influx contributes to the dysfunction of the RV,
since partial blockade of neutrophil influx with anti-PMN
antibodies or with anti-CINC antibodies reduces the devel-
opment of acute RV dysfunction (Watts et al. 2006; Zagor-
ski et al. 2007). The present study shows that the neutrophil
influx was resolved between day 4 and week 1 after PE,
while the monocytes persist through week 6.
The roles of monocytes in acute heart function and car-
diac healing after PE are just beginning to be defined. We
examined gene expression by focusing upon markers that
have been identified in the literature in M1 vs. M2 mono-
nuclear cells (Mantovani et al. 2005; Yrlid et al. 2006;
Zymek et al. 2006; Martinez et al. 2006, 2008). The profiles
of expression suggest that the macrophage response is bipha-
sic after PE, with the M1 pro-inflammatory phenotype pres-
ent on day 1 and the M2 healing phenotype predominating
at week 6. The localization of CD68+ cells also changed
throughout the 6-week period of the study. These cells were
observed in clusters on day 1 and encompassed the entire
wall of the RV outflow tract by week 1 after PE. By 6 weeks
after PE, the CD68+ cells seemed to decrease in number and
were observed in the loose tissue outside the collagen-rich
subendocardial region during scar formation. Smooth
muscle-positive cells accumulated in the endocardial side of
the transparent outflow tract and formed small neovessels in
the region showing deposition of collagen filaments. Recent
studies show that platelet-derived growth factor (PDGF) acts
upon receptor subtypes PDGFRa and PDGFRb in healing
left ventricle to promote fibroblast recruitment, development
and maturation of neovessels required for normal collagen
deposition and scar formation in the left ventricle (Zymek
et al. 2006). The present data are consistent with a role of
PDGF in development of the neovessels observed with the a-
SMA stain, since PDGFR1 and PDGFRb were significantly
elevated in the RV at 6 weeks of PE in this study.
The relevance of the model used to produce the PE in this
study should be considered. The microsphere model should
not directly induce systemic inflammation or directly cause
cardiac ischaemia and the model should produce cardiac
inflammation and regional dysfunction that is similar to that
observed in the clinical setting of PE. Several observations
suggest that it is unlikely that the polystyrene microspheres
directly activate circulating inflammation pathways. First,
there is no evidence of inflammation occurring in the left
ventricle of the heart. Second, RV inflammation and dys-
function are associated with moderate pulmonary hyperten-
sion and not just the presence of microspheres in the lungs
(Watts et al. 2006). Third, when microspheres were co-cul-
tured with rat pulmonary artery endothelial cells in a ratio
similar to that observed in vivo, there was no evidence of
stimulation of endothelial cell message for chemokines
(Zagorski et al. 2003). The microspheres do not directly
cause cardiac ischaemia when infused into the jugular vein,
since microspheres have not been observed in histological
studies of the right or left ventricle, while they are clearly
visible within the lungs, and the left ventricle is not damaged
(Zagorski et al. 2003; Watts et al. 2006). Thus, RV injury
is secondary to increased pulmonary resistance.
The model produces RV damage that is similar to clinical
PE. Case studies of human RV tissue obtained at autopsy
after PE show that neutrophil and monocyte ⁄macrophage
cells are present (Iwadate et al. 2001, 2003). Humans with
PE also have elevated circulating concentrations of myelop-
eroxidase, as well as other inflammatory biomarkers (Moyad
2001; Smulders 2001). Furthermore, the defects found in
human hearts occur in the pulmonary outflow tract of the
RV (McConnell et al. 1996), which is the location of injury
observed in this study of the rat hearts. Thus, humans have
inflammatory responses and RV dysfunction like those
observed in the rat model.
The RV comprised three components, including the inlet,
the apical myocardium and the pulmonary outflow tract
(infundibulum or conus region). Several differences among
these regions may explain why the outflow tract is the focus
of injury in the setting of an abrupt rise in pulmonary resis-
tance. First, the apical myocardium and the outflow tract
have different embryologic derivations (Dell’Italia 1991).
Second, the apical myocardium is thicker and trabeculated,
while the outflow tract is thinner and smooth. Third, the
outflow tract contracts 25–50 ms later than the apical
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region, allowing blood to move upward from the apical
region into the outflow tract before being ejected into the
pulmonary artery (Dell’Italia 1991; Haddad et al. 2008).
Thus, the outflow tract distends outward during the early
part of the systolic phase of the cardiac cycle as a result of
having thinner muscularity and delayed contraction. With
increased pulmonary resistance that occurs abruptly during
PE, the outflow tract would be expected to experience
greater stretch, increased shear forces and more compression
of coronary circulation than the apical region. At present, it
is not clear which of these factors contributes to the upregu-
lation of inflammation and the development of dysfunction.
Mortality and morbidity increase dramatically after PE
when there is RV dysfunction (Kasper et al. 1997; Ribeiro
et al. 1997; Ribeiro et al. 1999; Kreit 2004; Schoepf et al.
2004) and release of cardiac biomarkers, such as troponin
(Giannitsis et al. 2000; Meyer et al. 2000; Kline et al. 2006;
Lippi and Favaloro 2008). Our recent clinical studies find
that 40% of patients with PE of severity similar to that in
the rat model have persistent RV dysfunction with func-
tional cardiopulmonary limitations, independent of co-
morbid state (Kline et al. 2006; Stevinson et al. 2007). The
present study describes the early, monophasic response of
the neutrophils and suggest a biphasic response of mono-
cytes, continuing during the progression of hearts into the
resolution of inflammation and early stages of scar forma-
tion in the rat. Thus, the events described in the rat model
may provide a tool to determine if regulation of the acute
inflammatory phase induced by the abrupt increase in pul-
monary resistance to flow may improve the chronic recovery
of heart function.
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